Vir Says Its Best-In-Class COVID-19 Antibody Profile Is Holding Up

 
• By Jessica Merrill
COVID-19 graphic
Phase III data on Vir/GSK's antibody against COVID-19 is expected in Q1 • Source: Shutterstock

More from COVID-19

More from Scrip